Microkeratome users benefit from control, safety, performance
Philadelphia-The K-TOME microkeratome offers a range of desirable characteristics that make it an excellent choice for refractive surgeons, but unsurpassed control tops that feature list, said J. Charles Casebeer, MD. He spoke about the instrument, introduced in 1997 by Innovative Optics. Paradigm Medical Industries acquired that company last January and launched the K-TOME at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) here.
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.